评估用lutikizumab治疗的骨关节炎中生物力学变化的促进:系统性审查和元分析
Haiyang Kou1, Huaiquan Liu1, Lingyan Lai1
1College of Acumox and Tuina, Guizhou University of Traditional Chinese Medicine, Gui Yang, Guizhou, China.
Postgraduate medicine
|February 3, 2026
概括
在骨关节炎 (OA) 患者中,lutizumab有效降低了IL-α,IL-1β和hsCRP等炎症标志物. 这项研究提供了lutikizumab的证据.
科学领域:
- 风湿病学和免疫学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 骨关节炎 (OA) 是一种由炎症为特征的退行性关节疾病.
- 洲际蛋白-1 (IL-1) 在OA的发病过程中起着至关重要的作用,调解炎症和组织损伤.
- 准IL-1通路为OA管理提供了一个潜在的治疗策略.
研究的目的:
- 评估在被诊断患有骨关节炎 (OA) 的患者中lutikizumab的治疗疗效.
- 提供基于证据的参考资料,用于lutikizumab在OA治疗中的临床应用.
- 评估卢提基祖马布对OA关键炎症标志物的影响.
主要方法:
- 在主要数据库 (PubMed,Embase,Web of Science,Cochrane Library) 中进行了系统的文献搜索.
- 相关研究包括随机对照试验 (RCT),临床试验和非随机对照试验,调查OA治疗干预措施.
- 使用RevMan 5.4进行了元分析,以综合包括6项涉及737名患者的RCT的数据.
主要成果:
- 与对照组相比,lutizumab干预显示IL-α,IL-1β和高灵敏性C反应蛋白 (hsCRP) 水平显著降低.
- 具体发现包括IL-α (MD = -0.67),IL-1β (MD = -0.58) 和hsCRP (MD = -1.79) 的减少.
- 对所有评估的炎症标志物 (p < 0.05) 观察到统计学意义.
结论:
- 卢提基祖马布干预有效调节关键的炎症调解器在骨关节炎.
- 这些发现支持lutikizumab在缓解奥氏体炎症背后的炎症过程中的作用.
- 这项研究为进一步研究lutikizumab在关节炎管理中的治疗潜力提供了基础.
相关概念视频
Review and Preview
8.4K
In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview
11.4K
Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.4K
The Eukaryotic Promoter Region
18.8K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
The Eukaryotic Promoter Region
4.0K
4.0K
Random and Systematic Errors
15.1K
Scientists always try their best to record measurements with the utmost accuracy and precision. However, sometimes errors do occur. These errors can be random or systematic. Random errors are observed due to the inconsistency or fluctuation in the measurement process, or variations in the quantity itself that is being measured. Such errors fluctuate from being greater than or less than the true value in repeated measurements. Consider a scientist measuring the length of an earthworm using a...
15.1K
Directing Effect of Substituents: meta-Directing Groups
6.0K
Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
6.0K


